Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Arthritis Research & Therapy
|
December 2, 2008
Regulatory T cells in systemic lupus erythematosus: past, present and future
David A Horwitz
Immunity
|
September 19, 2006
Transforming growth factor-beta: taking control of T cells' life and death
David A Horwitz
Arthritis Research & Therapy
|
February 4, 2010
Identity of mysterious CD4+CD25-Foxp3+ cells in SLE
David A Horwitz
Frontiers in Immunology
|
December 10, 2025
CD2 targeted nanoparticles containing IL-2 mimic fetal-maternal tolerance of pregnancy by inducing synergistic TGF-β-producing NK cells and Tregs
David A Horwitz, Antonio La Cava
Current Opinion in Critical Care
|
July 11, 2008
Trauma rehabilitation outcome scoring
David A Horwitz, Douglas J E Schuerer
The Journal of Rheumatology
|
April 1, 2005
Development of Crohn's disease in a patient taking etanercept
Jenny Oh, Daniel G Arkfeld, David A Horwitz
Frontiers in Immunology
|
July 2, 2021
Strategies to Use Nanoparticles to Generate CD4 and CD8 Regulatory T Cells for the Treatment of SLE and Other Autoimmune Diseases
David A Horwitz, Sean Bickerton, Antonio La Cava
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2008
Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6
Song Guo Zheng, Juhua Wang, David A Horwitz
Journal of Leukocyte Biology
|
October 2, 2003
The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets
David A Horwitz, Song Guo Zheng, J Dixon Gray
Trends in Immunology
|
August 5, 2008
Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other
David A Horwitz, Song Guo Zheng, J Dixon Gray
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Arthritis Research & Therapy
|
December 2, 2008
Regulatory T cells in systemic lupus erythematosus: past, present and future
David A Horwitz
Immunity
|
September 19, 2006
Transforming growth factor-beta: taking control of T cells' life and death
David A Horwitz
Arthritis Research & Therapy
|
February 4, 2010
Identity of mysterious CD4+CD25-Foxp3+ cells in SLE
David A Horwitz
Frontiers in Immunology
|
December 10, 2025
CD2 targeted nanoparticles containing IL-2 mimic fetal-maternal tolerance of pregnancy by inducing synergistic TGF-β-producing NK cells and Tregs
David A Horwitz, Antonio La Cava
Current Opinion in Critical Care
|
July 11, 2008
Trauma rehabilitation outcome scoring
David A Horwitz, Douglas J E Schuerer
The Journal of Rheumatology
|
April 1, 2005
Development of Crohn's disease in a patient taking etanercept
Jenny Oh, Daniel G Arkfeld, David A Horwitz
Frontiers in Immunology
|
July 2, 2021
Strategies to Use Nanoparticles to Generate CD4 and CD8 Regulatory T Cells for the Treatment of SLE and Other Autoimmune Diseases
David A Horwitz, Sean Bickerton, Antonio La Cava
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2008
Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6
Song Guo Zheng, Juhua Wang, David A Horwitz
Journal of Leukocyte Biology
|
October 2, 2003
The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets
David A Horwitz, Song Guo Zheng, J Dixon Gray
Trends in Immunology
|
August 5, 2008
Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other
David A Horwitz, Song Guo Zheng, J Dixon Gray
Page
of 4